Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
9 shown of 9,566 total abstracts
  1. Abstract 102972026-04-03 · 21:15 CT · S100A
    CheckMate-265: Opdivo (nivolumab) neoadjuvant in metastatic melanoma
    G. Curigliano, M. Reck, T. Mok, et al. · University of Chicago
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  2. Abstract 99682026-04-03 · 21:45 CT · Hall B1
    Quality of life outcomes with Keytruda in patients with metastatic melanoma
    R. Herbst, C. Robert, E. Winer, et al. · Dana-Farber Cancer Institute
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  3. Abstract 103752026-04-04 · 16:00 CT · Arie Crown Theater
    CheckMate-398: Opdivo (nivolumab) 1L in metastatic melanoma
    F. Andre, P. Schmid · Chinese University of Hong Kong
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  4. Abstract 98362026-04-02 · 19:45 CT · S406
    CheckMate-233: Opdivo (nivolumab) maintenance in metastatic melanoma
    J. Brahmer, S. Modi, C. Saura · Massachusetts General Hospital
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  5. Abstract 99042026-04-03 · 18:30 CT · S100A
    Real-world effectiveness of Opdivo vs standard of care in metastatic melanoma
    S. Tolaney, J. Brahmer · Stanford Cancer Institute
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  6. Abstract 101302026-04-05 · 20:15 CT · E450
    Keytruda plus chemotherapy in previously untreated metastatic melanoma: updated analysis from KEYNOTE-824
    J. Brahmer, C. Robert, S. Modi · National Cancer Center Japan
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  7. Abstract 101782026-04-04 · 14:45 CT · E450
    Biomarker subgroup analysis of Keytruda in metastatic melanoma (the KEYNOTE-905 study)
    T. Mok, E. Winer, P. Schmid · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  8. Abstract 97462026-04-01 · 14:45 CT · S100A
    Long-term follow-up of Keytruda adjuvant for metastatic melanoma: KEYNOTE-845
    F. Andre, N. Rizvi, S. Peters · Karolinska Institute
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  9. Abstract 102592026-04-01 · 14:45 CT · S406
    KEYNOTE-142: Keytruda (pembrolizumab) neoadjuvant in metastatic melanoma
    H. Rugo, N. Rizvi, S. Tolaney, et al. · Chinese University of Hong Kong
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.